What does Platinib treat? What is the effect?

Pralsetinib belongs to the class of anti-tumor drugs (cancer drugs). It works by interfering with the growth of cancer cells, which will eventually be destroyed. Platinib is used to treat metastatic non-small cell lung cancer (NSCLC) and patients whose tumors have RET fusion-positive genes. Platinib is also used to treat tumors with abnormalitiesRET (RETmutant)Advanced or metastatic (cancer that has spread)Medullary thyroid carcinoma(MTC). Platinib is also used to treat patients with advanced or metastatic (cancer that has spread) thyroid cancer whose tumors harbor a RET fusion-positive gene.

ARROW A multi-cohort, open-label, Phase 1/2 study at 71 sites (community and academic cancer centers). Patients aged 18 years or older with locally advanced or metastatic solid tumors, including RET fusion-positive non-small cell tumors, were recruited. cell lung cancer, and Eastern Cooperative Oncology Group performance status was 0-2 (later restricted to 0-1 in a protocol amendment). On2017year3month17to< /span>2020Year5Month22Recruited between233namesRETNumber of fusion-positive non-small cell lung cancer patients( As of ), 92patients had previously received platinum-based chemotherapy, 29patients who received treatment for the first time on 2019year7month11 day Previously treated with platinib; 87 previously treated patients and 27 first-time treated patients were collectively judged to have baseline measurable disease. The overall response was recorded at 53 (61%; 95% CI 50-71 ),including5patients(6%)who had complete remission; and19 (70%;50-86), including 3cases(11%)complete remission. Among 233casesRETfusion-positive NSCLC, the common Grade 3 or worse treatment-related adverse event was neutropenia(43cases[18%], hypertension (26 [11%]), and anemia (24 [10%]). Platinib is a new, well-tolerated, promising once-daily oral treatment option for patients with RETfusion-positive non-small cell lung cancer. This medicine also has an overseas version. The retail price of Lucius Pharmaceuticals in Laos is more than 1,000 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.